O. Cem Et Al. , "The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.," ASCO-SITC Clinical Immuno-Oncology Symposium , vol.37, San-Francisco, Costa Rica, 2019
Cem, O. Et Al. 2019. The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.. ASCO-SITC Clinical Immuno-Oncology Symposium , (San-Francisco, Costa Rica).
Cem, O., Sedef, A. M., Kose, F., Oymak, E., Guler, O. C., Sumbul, A. T., ... Aksoy, S.(2019). The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. . ASCO-SITC Clinical Immuno-Oncology Symposium, San-Francisco, Costa Rica
Cem, Onal Et Al. "The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.," ASCO-SITC Clinical Immuno-Oncology Symposium, San-Francisco, Costa Rica, 2019
Cem, Onal Et Al. "The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.." ASCO-SITC Clinical Immuno-Oncology Symposium , San-Francisco, Costa Rica, 2019
Cem, O. Et Al. (2019) . "The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.." ASCO-SITC Clinical Immuno-Oncology Symposium , San-Francisco, Costa Rica.
@conferencepaper{conferencepaper, author={Onal Cem Et Al. }, title={The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.}, congress name={ASCO-SITC Clinical Immuno-Oncology Symposium}, city={San-Francisco}, country={Costa Rica}, year={2019}}